Govt agrees with experts - class B for Fantasy 2/3

Tariana Turia Associate Minister of Health

BACKGROUND INFORMATION

Misuse of Drugs Legislation
In
mid-November 2000 the Misuse of Drugs Amendment Act was passed.

This new law enables New Zealand to respond more quickly to emerging drug
threats than was previously the case. Previously, scheduling of substances under
the Act could only be done by way of Parliament amending the Act in the normal
way. The passage of amendments to legislation can take some time.

While under the new process parliament will still have the final say, the
scheduling of substances will be able to be made on a regular basis and faster
than before.

Expert Advisory Committee on Drugs
A
vital part of this process will be the Expert Advisory Committee on Drugs
(EACD), which was been established to advise the Minister of Health. The EACD
will:

  • Conduct evidence-based reviews of controlled drugs and other narcotic, or,
    psychotropic substances
  • Recommend to the Minister about whether and how such substances should be
    classified
  • Increase public awareness of its work by (for instance) releasing papers,
    reports and recommendations

Membership of the Expert Advisory Committee on Drugs

Dr Bob Boyd Ministry of Health Chief Advisor
Public Health Directorate (chair)
Dr
Stewart Jessamine
Medsafe Senior Medical Advisor
Det
Insp Harry Quinn
NZ
Police
Mr
Andrew Coleman
NZ
Customs
Dr
Keith Bedford
Expertise in toxicology
Assoc
Prof Tim Maling
Expertise in pharmacology
Dr
Helen Moriarty
Expertise in community medicine
Dr
Geoffrey Robinson
Expertise in drug and alcohol treatment
Dr
Douglas Sellman
Expertise in psychology
Mr
Keremete Warbrick
Representing the views of consumers of drug treatment
services

Terms of Reference
Under the Terms of
Reference, there are two ways in which a drug maybe considered by the committee.
First, the Minister of Health or the EACD Secretariat may refer a drug to the
EACD for consideration. Members of the public can also feed into this process by
writing to the EACD Secretariat in the Ministry of Health ww.ndp.govt.nz).
Second, the EACD may itself decide to examine the classification of a particular
drug.

Details of the drugs to be considered at future Committee meetings are to be
published on the National Drug Policy website, and interested parties can make
written submissions on drugs the EACD have decided to examine.

However, all written submissions should follow a set format and the EACD will
appreciate evidence-based submissions. Full details about the process for
written submissions will shortly be available on the National Drug Policy
website (ww.ndp.govt.nz).

Hospitalisation through use of Fantasy

A regional breakdown of figures is not available nationally. Local DHBs may
be able to assist in this area, however, accuracy cannot be guaranteed, as
patients seen or admitted to hospital must voluntarily identify that they have
used Fantasy.

Class B
Class B has three parts, B1,
B2, and B3. When drugs are classified as B1 as opposed to B2 or B3 police have
wider enforcement powers including the ability to search premises and people
without a warrant if they have reasonable grounds to believe an offence has been
committed under the Misuse of Drugs Act 1975. The same enforcement powers are
applied to drugs scheduled in A and C1.